COMT and hyperhomocysteinemia: Recently a unifying hypothesis that hyperhomocysteinemia may exert its pathogenic effects largely through the metabolic accumulation of SAH, which is a potent non-competitive inhibitor of COMT mediated methylation of various catechol substrates, such as catecholamines and catechol estrogens has been proposed [10].